Insulin signaling in health and disease
Open accessThe DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms of cellular insulin action have been the focus of much investigation since the discovery of the hormone 100 years ago. Insulin action is impaired in metabolic syndrome, a condition known as insulin resistance. The actions of the hormone are initiated by binding to its receptor on the surface of target cells. The receptor is an α2β2 heterodimer that binds to insulin with high affinity, resulting in the activation of its tyrosine kinase activity. Once activated, the receptor can phosphorylate a number of intracellular substrates that initiate discrete signaling pathways. The tyrosine phosphorylation of some substrates activates phosphatidylinositol-3-kinase (PI3K), which produces polyphosphoinositides that interact with protein kinases, leading to activation of the kinase Akt. Phosphorylation of Shc leads to activation of the Ras/MAP kinase pathway. Phosphorylation of SH2B2 and of Cbl initiates activation of G proteins such as TC10. Activation of Akt and other protein kinases produces phosphorylation of a variety of substrates, including transcription factors, GTPase-activating proteins, and other kinases that control key metabolic events. Among the cellular processes controlled by insulin are vesicle trafficking, activities of metabolic enzymes, transcriptional factors, and degradation of insulin itself. Together these complex processes are coordinated to ensure glucose homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 1×
“Ser473 appears to be phosphorylated mainly by the rapamycin-insensitive mTOR complex mTORC2 (80).”
BackgroundAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · cited 7×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialInsulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“The tyrosine residues phosphorylated in each substrate occur in specific sequence motifs; once phosphorylated, they serve as docking sites for intracellular molecules containing SH2 (Src homology 2) domains (1).”
BackgroundSelf-citationInhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · cited 6×
“Rommel C, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/ mTOR and PI(3)K/Akt/GSK3 pathways.”
BackgroundInfluentialCellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · cited 1×
“In part, variability may reflect the presence of three Akt isoforms (88).”
BackgroundDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359 · cited 2×
“Hirosumi J, et al. A central role for JNK in obesity and insulin resistance.”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826 · cited 1×
“PI-(3,4,5)P3 recruits the serine/threonine kinase phosphoinositide-dependent kinase 1 (PDK1) to the plasma membrane through its PH domain and phosphorylates Thr308 on Akt (78, 79).”
BackgroundCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · cited 5×
“Other AGC kinases activated downstream of PI3K include the protein kinase C (PKC) family, particularly PKC-ζ.”
BackgroundInfluential
Research works printed but not linked: 4
- Kido, 2001, Clinical review 125: The insulin receptor and its cellular targets, J Clin Endocrinol Metab, 86, 972
- O-Sullivan, 2015, FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization, Nat Commun, 6
- 10.1172/JCI23096 · doi:10.1172/jci23096 · Paper page
- 10.1210/jcem.82.6.3979 · doi:10.1210/jcem.82.6.3979 · Paper page
Cited by
Items 201–300 of 448
Dysregulation of BMP, Wnt, and Insulin Signaling in Fragile X Syndrome
Song, C., & Broadie, K. S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.934662 · Cited by 10
“These secreted signals are critical for numerous cell regulatory processes; including proliferation, differentiation, migration, growth, function, and programmed death (Sedlmeier and Sleeman, 2017; Ng et al., 2019; Saltiel, 2021).”
BackgroundLiu, M. A., Shahabi, S., Jati, S., Tang, K., Gao, H., Jin, Z., Miller, W., Meunier, F. A., Ying, W., van den Bogaart, G., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1037465 · Cited by 7
“Insulin promotes glucose uptake by signaling via the serine/ threonine kinase AKT (52).”
BackgroundThe Common Single Cause of Chronic Multi-Hormonal Resistance in Oxidative Stress
Wittmann, I. (2022) · Antioxidants · doi:10.3390/antiox12010075 · Cited by 8
“Defects of both tyrosine phosphorylation and dephosphorylation are responsible for insulin resistance, although, abnormalities of activation of different PKC isoforms also play a role, however, their selective inductions are not completely independent from the tyrosine cascade [10], but glucometabolic effect of insuli…”
BackgroundJørgensen, S. H., Emdal, K. B., Pedersen, A.-K., Axelsen, L. N., Kildegaard, H. F., Demozay, D., Pedersen, T. Å., Grønborg, M., Slaaby, R., Nielsen, P. K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-77817-5 · Cited by 7
Alves, S. S., Rossi, L., de Oliveira, J. A. C., Servilha‐Menezes, G., Grigório-de-Sant’Ana, M., Mazzei, R. F., Almeida, S. S., Sebollela, A. S., da Silva-Júnior, R. M. P., & Garcia‐Cairasco, N. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04844-2 · Cited by 7
Xu, H., Jiang, N., Chen, G., He, Y., Xiong, J., Chen, D., Liu, Y., Wu, Y., & Zhao, C. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119937 · Cited by 8
Parkinson’s disease and brain insulin signaling: Mechanisms and potential role of GLP-1 mimetics
Foroozanmehr, B., Hemmati, M. A., Yaribeygi, H., Karav, S., Jamialahmadi, T., & Sahebkar, A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149738 · Cited by 6
SHARMA, A. K., Mannan, A., & Singh, T. G. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01642-6 · Cited by 9
Bizingre, C., Arellano-Anaya, Z. E., Picard, F., Pietri, M., Baudry, A., Roussel, F. S., Bianchi, C., Alleaume‐Butaux, A., Ardila-Osorio, H., Romao, M., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70114 · Cited by 8
Theivendren, P., Gopalakrishnan, P., Sivakumar, A., Pachiappan, S., Chimakurthy, J., & Murugavel, A. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100375 · Cited by 9
Nanomaterials for the treatment and monitoring of obesity: Targeting adipose tissue macrophages
Tang, Y., Chen, O., Dong, B., Liu, L., Ying, W., & Liu, H. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.09.052 · Cited by 10
Baek, K.-R., & Kim, H. (2025) · Molecules · doi:10.3390/molecules30204111 · Cited by 8
“Normally, insulin binding initiates receptor autophosphorylation and IRS protein activation, triggering PI3K/Akt signaling and promoting GLUT4 expression and translocation [40].”
Impact of type 2 diabetes on malignancies of the female reproductive system
Espinoza, C., Veas-Torres, J., Miranda, D. I., & Owen, G. I. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101459 · Cited by 6
Simon‐Szabó, L., Lizák, B., Sturm, G., Somogyi, A., Takács, I., & Németh, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25169113 · Cited by 10
“All the effects of insulin are mediated by its receptor, and depend on tissue targets, other hormones, biogenic amines, and their temporal relationship [47].”
BackgroundLee, J. I., Lee, H. M., Park, J., & Lee, Y. G. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70010 · Cited by 6
BACE1 Inhibition Protects Against Type 2 Diabetes Mellitus by Restoring Insulin Receptor in Mice
Lin, T., Liang, T. X., Shen, Y., & Gao, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115100 · Cited by 6
“InsR is a type 2 receptor tyrosine kinase that could activate the downstream IRS-PI3K-AKT pathway, playing essential roles in regulates glucose metabolism by phosphorylating various downstream proteins, which is closely associated with insulin resistance and diabetes mellitus [5–10].”
Proteomics profiles of blood glucose-related proteins involved in a Chinese longevity cohort
Zhang, R., Liu, F., Ye, S., Du, X., Ma, L., Cao, H., Wang, Z., & Li, C. (2022) · Clinical Proteomics · doi:10.1186/s12014-022-09382-w · Cited by 7
The Relationship between Insulin Resistance and Thyroid Volume in Georgia
Lomtadze, N., Giorgadze, E., Janjgava, S., Kacharava, T., & Taboridze, I. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230220093432 · Cited by 11
Mathew, D., Barillas, J., Nedeljkovic-Kurepa, A., Abraham, M. N., Taylor, M. D., & Deutschman, C. S. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00703-9 · Cited by 6
“Insulin binding activates tyrosine kinase activity in the β subunit (IRβ) which auto-phosphorylates and then acts as a tyrosine kinase to phosphorylate members of a family of molecules collectively called Insulin Receptor Substrates (IRSs) (White and Kahn 2021; Saltiel 2021).”
BackgroundTryptophanylation of insulin receptor by WARS attenuates insulin signaling
Sun, W.-X., Zhang, K.-H., Zhou, Q., Hu, S., Lin, Y., Xu, W., Zhao, S., & Yuan, Y. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05082-2 · Cited by 8
Diabetes and cognitive dysfunction
Kim, B., Sims‐Robinson, C., Sakowski, S. A., & Feldman, E. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00027-7 · Cited by 8
Insulin receptor loss impairs mammary tumorigenesis in mice
Podmore, L., Poloz, Y., Iorio, C., Mouaaz, S., Nixon, K., Smirnov, P., McDonnell, B., Lam, S. H. L., Zhang, B., Tharmapalan, P., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113251 · Cited by 8
Ding, C., Jia, Y., Liu, L., Wang, W., Zhou, D., Zhou, Z., Yang, L., Chen, X., Chen, D., Mao, Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202502763 · Cited by 8
Zermeño-Ruiz, M., Gutiérrez-Gutiérrez, F., Anaya-Ambriz, E. J., Peña-Durán, E., García-Galindo, J. J., Huerta-Huerta, A., Quiñonez-Gallardo, A. L., & Suárez-Rico, D. O. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031610 · Cited by 8
“This modification not only attenuates downstream signaling but also facilitates proteasomal degradation of IRS proteins, further decreasing insulin sensitivity [12].”
Unraveling the complexity of the histone code: implications for gene regulation and disease
Malone, K. L., Singh, A. K., Lignos, J. M., Cook, E. D., Phillips, M., Boyle, B. W., Kressy, I. A., Vulikh, M., Lathrop, A. K., McKay, K. T., et al. (2026) · Genome biology · doi:10.1186/s13059-026-04011-3 · Cited by 7
The PCOS puzzle: putting the pieces together for optimal care
Dar, M. A., Maqbool, M., & Ara, I. (2023) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2023-0102 · Cited by 7
FKBP5 as a key regulator of metabolic processes in birds: Insights from chicken pectoral muscle
Du, P., Zhang, X., Zhu, Y., Wang, Z., Si, X., Zhang, H., Huang, Y., & Chen, W. (2024) · Poultry Science · doi:10.1016/j.psj.2024.104657 · Cited by 5
Wander, P. L., Enquobahrie, D. A., Bammler, T. K., MacDonald, J. W., Srinouanprachanh, S. L., Kaleru, T., Khakpour, D., & Trikudanathan, S. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111723 · Cited by 8
Monro, J. A., Mishra, S. S., Stoklosinski, H. M., Bentley‐Hewitt, K. L., HEDDERLEY, D. I., Dinnan, H., & Martell, S. (2022) · Nutrients · doi:10.3390/nu14153189 · Cited by 8
GLUT4 dispersal at the plasma membrane of adipocytes: a super-resolved journey
Geiser, A., Foylan, S., Tinning, P. W., Bryant, N. J., & Gould, G. W. (2023) · Bioscience Reports · doi:10.1042/bsr20230946 · Cited by 5
Msane, S., Khathi, A., & Sosibo, A. M. (2025) · Nutrients · doi:10.3390/nu17020292 · Cited by 7
Wang, J., Luo, Y., Liu, Y., Tang, X., Gu, J., Huang, Z., Lv, T., Luo, J. P., & Fang, G. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01685-4 · Cited by 5
Resveratrol Impairs Insulin Signaling in Hepatic Cells via Activation of PKC and PTP1B Pathways
Hernández-González, K. D., Vinchira-Lamprea, M. A., Hernández-Aranda, J., & Olivares-Reyes, J. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157434 · Cited by 4
“Akt triggers several metabolic processes, including glycogen synthesis, protein synthesis, and adipogenesis [37].”
InfluentialDeciphering the significant impact of natural glycosylation on human insulin
Li, Y., Liu, W., Liu, D., Wang, R., Zhang, Y., Li, X., Gong, J., Shang, S., & Tan, Z. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.08.005 · Cited by 4
“While insulin primarily activates the PI3K/AKT pathway, it also modulates additional signaling cascades, such as the CRK/ TC10 pathway (regulating metabolic responses) and the Ras/ MAPK pathway (mediating mitogenic effects) 43,44 .”
Targeting Kinase Suppressor of Ras 1 (KSR1) for Cancer Therapy
Moon, H., Park, H., Lee, S., Lee, S.-H., & Ro, S. W. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17101348 · Cited by 5
“Its dual-domain architecture supports both membrane localization and interaction with activated RTKs [21,31]. β -arrestins 1 and 2, traditionally known for their roles in GPCR desensitization and internalization, also serve as docking proteins for MAPK signaling.”
Alawaji, R., Abdel‐Bakky, M. S., Ali, H. M., Aljuhani, M. A., Alshammari, A. A. A., Kamal, H. K., Khoja, M. T., Alsehemi, K., Korani, M. A., & Said, E. S. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.70083 · Cited by 4
Reversal of diet-induced obesity by central insulin sensitizer FSTL1
Li, K., Dai, H., Li, L., Qiu, S., Liu, D., Wang, C., Li, S., Yang, G., Li, L., Li, M., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.09.036 · Cited by 6
Local Insulin for Local Needs? Insights into Retinal Insulin Signaling and RPE Metabolism
Balbi, M., Puddu, A., Amaroli, A., Maggi, D. C., Panfoli, I., & Ravera, S. (2025) · Biomolecules · doi:10.3390/biom15111570 · Cited by 5
Abdullah, K. M., Sharma, G., Anjum, B., Alam, M. F., Yadav, S., Singh, Y., Sinha, R. A., Venkatesh, V., Siddiqui, J. A., & Chakravarti, B. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101458 · Cited by 4
Suzuki, T., Sato, T., Masuhara, K., Tokusanai, M., Akatsuka, H., Kashikawa, T., & Suzuki, Y. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s430132 · Cited by 5
Maggio, J., Armando, R. G., Balcone, L., Vilarullo, R., Casco, M. D. P., Gómez, D. L. M., & Gomez, D. E. (2023) · World Academy of Sciences Journal · doi:10.3892/wasj.2023.220 · Cited by 3
Tao, G., Wang, X., Wang, J., Ye, Y., Zhang, M., Yan, L., & Ding, S. (2025) · The EPMA Journal · doi:10.1007/s13167-024-00394-0 · Cited by 4
Rao, Y., Li, J., Xu, T., Gao, L., & Wang, W. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01632-3 · Cited by 4
Soleimani, A., Maghsoodi, M., Bahrani, S., Amerizadeh, A., & Teimouri-Jervekani, Z. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04646-3 · Cited by 5
Liu, L., Chen, Z., Wang, D., Liang, W., Wang, B., Xia, C., Yan, Y., Ding, C., Meng, X., & Liang, H. (2025) · Biomolecules · doi:10.3390/biom15060894 · Cited by 4
Kioumourtzoglou, D., Black, H. L., Tobi, M. A., Livingstone, R., Petrie, J. R., Boyle, J. G., Gould, G. W., & Bryant, N. J. (2023) · Biomolecules · doi:10.3390/biom13121738 · Cited by 4
“Insulin exerts its effects through binding cell surface receptors, activating their tyrosine kinase activity [15].”
BackgroundLiu, X., Liu, Y., Ding, Y., Gong, W., Qian, H., Jin, K., Niu, Y., Zuo, Q., Song, J., Han, W., et al. (2024) · Poultry Science · doi:10.1016/j.psj.2024.104140 · Cited by 4
“The physiological functions of insulin are mediated primarily via activation of the PI3K/AKT signal transduction pathway (Saltiel, 2021).”
BackgroundKarampelias, C., Băloiu, B., Rathkolb, B., da Silva‐Buttkus, P., Bachar-Wikström, E., Marschall, S., Fuchs, H., Gailus‐Durner, V., Chu, L., de Angelis, M. H., et al. (2024) · Life Science Alliance · doi:10.26508/lsa.202402771 · Cited by 4
Oxidative Stress and Antioxidant Interventions in Type 2 Diabetes
Sohail, A., Hasnain, M. M., Haq, M. E. U., Nasir, I., Sufyan, R., Khan, M., & Ullah, I. (2024) · Biochemistry · doi:10.5772/intechopen.1006081 · Cited by 9
Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats
Zhao, F., Cui, W., Fang, C., Luo, Y., & Zhang, C. (2024) · Journal of Ovarian Research · doi:10.1186/s13048-024-01554-6 · Cited by 5
Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors
Qiao, M., Ni, J., Qing, H., Qiu, Y., & Quan, Z. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04779-8 · Cited by 4
Noroozzadeh, M., Mousavi, M. A., Naz, M. S. G., Farahmand, M., Azizi, F., & Tehrani, F. R. (2025) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-025-01405-z · Cited by 8
Su, C., Wang, P., Lian, D., Sun, C., & Wang, C. (2025) · HORMONES · doi:10.1007/s42000-025-00699-3 · Cited by 10
Immediate-early transcriptional response to insulin receptor stimulation
Thiel, G., Wagner, L., Ulrich, M., & Rößler, O. G. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114696 · Cited by 4
Zakharova, I. O., Bayunova, L. V., Derkach, K. V., Ilyasov, I. O., Shpakov, A. O., & Avrova, N. F. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022020077 · Cited by 4
Du, N., Song, D., Sun, X., Ren, H., & Zhang, Y. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.102880 · Cited by 4
Karagözoğlu, F., Şahin, E., Melek, Ş., Şahin, S. B., Koca, R., Yüksel, H., & Güngören, A. (2025) · ACS Omega · doi:10.1021/acsomega.5c02662 · Cited by 5
de Deus, I. J., de Abreu, A. R. R., Fagundes, M. M. D. A., Silva, J. L., Breguez, G. S., Silva, Â. A., Siqueira, É. C. D. S. O., Carneiro, C. M., Costa, D. C., Paula-Gomes, S., et al. (2025) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174425100123 · Cited by 3
Larsen, A. T., Melander, S. A., Mohamed, K. E., Petersen, E. A., Benmarce, M., Karsdal, M. A., & Henriksen, K. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118388 · Cited by 3
Lin, Y., Hou, W., Ge, M., Wu, Z., Huang, L., Liu, H., Zhang, W., Deng, X., Wang, L., Guan, M., et al. (2025) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.1041 · Cited by 8
Suzawa, M., McPherson, W. K., Gorder, E. E. V., Reddy, S., Hilovsky, D. L., Keliinui, C. N., Jamali, L. A., & Bland, M. L. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2426930122 · Cited by 6
Abdalla, M. M. I., & Ismail-Khan, M. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i11.110185 · Cited by 8
Enhanced insulin signaling via circulating ATG7: A potential therapeutic strategy for diabetes
Guan, Y., Yu, Y., Fu, M., Xu, H., Lee, E., Wang, H., Moreno‐Navarrete, J. M., Deng, C., Li, Y., Song, K., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2503783123 · Cited by 4
Yeerbao, Z., Li, X., Zhang, L., Du, G., Tang, J., Jiang, S., Ru, X., Li, D., Abulimiti, D., Li, C., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1760943 · Cited by 3
“This is primarily mediated by serine phosphorylation of IRS proteins, which disrupts signal transduction (42, 43).”
Porphyra haitanensis glycoprotein regulates glucose homeostasis: targeting the liver
Ou, Y., Guo, Y., Wang, H., Guo, Z., & Zheng, B. (2024) · Food & Function · doi:10.1039/d4fo01544d · Cited by 3
Ayubi, N., Wibawa, J. C., Lesmana, H. S., Callixte, C., & Dafun, P. B. (2024) · Retos · doi:10.47197/retos.v59.104078 · Cited by 10
Intracellular calcium channels: Potential targets for type 2 diabetes mellitus?
Zhu, J.-X., Pan, Z.-N., & Li, D. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i4.98995 · Cited by 5
Hedaya, L., Naja, K., Almuraikhy, S., Anwardeen, N. R., Elashi, A. A., Al‐Asmakh, M., Zughaier, S. M., Espino‐Guarch, M., Al-Dirbashi, O. Y., Davey, G. P., et al. (2025) · Cells · doi:10.3390/cells14161296 · Cited by 4
“Lac-Phe significantly interrupted insulin signaling in C2C12 myotubes, including phosphorylated Akt, which is a hub protein affecting several vital targets in the studied pathway [23].”
Lin, J., Asai, S., Selicharová, I., Mitrová, K., Kaminský, J., Young, E., & Jiráček, J. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10499-1 · Cited by 3
Han, Q., Ding, Q., Yu, L., Li, T., Sun, B., & Tang, Z. (2023) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlad060 · Cited by 4
IVF exposure induced intergenerational effects on metabolic phenotype in mice
Ban, M., Feng, W., Hou, M., Zhang, Z., & Cui, L. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.103992 · Cited by 4
Guo, L., Zong, Y., Yang, W., Lin, Y., Feng, Q., Yu, C., Liu, X., Li, C., Zhang, W., Wang, R., et al. (2024) · FEBS Journal · doi:10.1111/febs.17198 · Cited by 6
A functional approach to homeostatic regulation
Arias, C. F., Acosta, F. J., Bertocchini, F., & Fernández-Arias, C. (2024) · Biology Direct · doi:10.1186/s13062-024-00577-9 · Cited by 4
Gao, Y., Gao, Y., Li, Y., Zhang, Q., & Wang, Y. (2025) · Medicine · doi:10.1097/md.0000000000041630 · Cited by 6
“…physiologically, insulin and insulin-like growth factor-1 (IGF-1), besides increasing glucose uptake, also increase protein synthesis, promote muscle hypertrophy, and inhibit protein degradation, [25] leading to an increase in skeletal muscle mass, which is strongly associated with frailty.”
Ali, S. I., Khaleel, F. M., & Ali, F. E. (2022) · Baghdad Journal of Biochemistry and Applied Biological Sciences · doi:10.47419/bjbabs.v3i04.151 · Cited by 7
Charlot, A., Bringolf, A., Mallard, J., Jaulin, A., Crouchet, É., Charles, A., Duteil, D., Alpy, F., Tomasetto, C., Baumert, T. F., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00498.2024 · Cited by 2
Wu, P., Cui, P., Wang, Y., & Chen, K. (2025) · Polyoxometalates · doi:10.26599/pom.2025.9140092 · Cited by 2
A novel covalent inhibitor alleviates type 2 diabetes mellitus by restraining GSK-3β
Zhang, S., Zhao, F., Pan, C., Wang, Y., Yang, Z., Yang, J., Meng, Y., Lv, S., Huang, J., Dong, L., et al. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117205 · Cited by 3
Mehmood, H., Alowami, M., Hlaing, T. S., Zaya, K. N., Uraiby, Y., Alam, A. M., Adala, A., Ikram, O., Ali, S. F., Farhan, M., et al. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70126 · Cited by 2
Yadav, S., Dadge, S. D., Rathaur, S., Maity, D., Prajapati, V. M., & Gayen, J. R. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103765 · Cited by 2
Yang, D., Song, X., Zeng, X., Cao, Z., Xiang, W., Xian, X., Yuan, L., Zhang, Z., & Zheng, Y. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08298-1 · Cited by 3
Insulin-stimulated endosomal trafficking of GLUT4 – a change to the model?
Kanzaki, M., & Gould, G. W. (2024) · Journal of Cell Science · doi:10.1242/jcs.264262 · Cited by 2
Shen, L., Ma, J., Liang, S., Yang, Y., Liao, T., Lei, Y., Chen, L., Wang, Y., Zhao, Y., Niu, L., et al. (2026) · npj Science of Food · doi:10.1038/s41538-026-00709-7 · Cited by 2
A bug’s life: diverse roles of insulin signaling in insect growth and development
Dunham, K. E., & Bland, M. L. (2026) · Current Opinion in Insect Science · doi:10.1016/j.cois.2026.101509 · Cited by 4
Gene regulatory mechanisms underlying sex- and age-dependent pathophysiology of MASLD
Morral, N. (2026) · Clinical Science · doi:10.1042/cs20250052 · Cited by 3
Kim, H. Y., & Yoo, Y. H. (2022) · Biomedicines · doi:10.3390/biomedicines10092082 · Cited by 2
A minireview of pharmacotherapy of type 2 diabetes – drugs and mechanisms
Lima, É. B. D. S., de Godoy, A. C. V., & de Araújo, S. (2022) · Research Society and Development · doi:10.33448/rsd-v11i12.34900 · Cited by 3
Yan, Z., Zong, Y., Zhang, C., Han, Z., Wu, L., Qin, L., & Liu, T. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1033128 · Cited by 2
“also functions as an anabolic hormone that promotes fatty acid and amino acid uptake, energy storage, and cell growth (Saltiel, 2021).”
BackgroundXie, L., Zhang, J., Zeng, P., Feng, Y., & Wu, X. (2023) · Chemistry & Biodiversity · doi:10.1002/cbdv.202300578 · Cited by 2
Bremner, S., Berends, R. F., Kaupisch, A., Roccisana, J., Sutherland, C. D., Bryant, N. J., & Gould, G. W. (2023) · PeerJ · doi:10.7717/peerj.15630 · Cited by 2
“The regulation of glucose transport is a central facet of insulin action ( Saltiel, 2021 ; Santoro, McGraw & Kahn, 2021 ).”
Stenckova, M., Liu, Y., Nekulová, M., Holčáková, J., Pokorná, Z., Nenutil, R., Thompson, A. M., Vojtěšek, B., & Coates, P. J. (2023) · Neoplasma · doi:10.4149/neo_2023_230719n376 · Cited by 2
Chen, W., & Kahn, C. R. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.09.001 · Cited by 3
Szkudelski, T., & Szkudelska, K. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167552 · Cited by 2
Fojas, E. G., Haidery, A., Naseeb, S., & Naemi, R. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109003 · Cited by 3
Yan, J., Hou, Q., Liu, J., & Li, W. (2025) · Biomedical Chromatography · doi:10.1002/bmc.70156 · Cited by 2
Cell fate‐inducing CARs orthogonally control multiple signaling pathways
Nakajima, K., Nakabayashi, H., & Kawahara, M. (2022) · Biotechnology Journal · doi:10.1002/biot.202100463 · Cited by 2
Whole-exome Sequencing Analysis of a Japanese Patient With Hyperinsulinemia and Liver Dysfunction
Fujita, S., Kawada-Horitani, E., Miyashita, Y., Fujita, Y., Fukui, K., Kamada, Y., Mineo, I., Asano, Y., Iwahashi, H., Kozawa, J., et al. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac008 · Cited by 2
Hyperinsulinemia and age-related diseases: interrelations and approaches to treatment
Martyushev-Poklad, A. V., Yankevich, D. S., Petrova, M. V., & Savitskaya, N. G. (2022) · Voprosy Pitaniya · doi:10.33029/0042-8833-2022-91-3-21-31 · Cited by 4
Wei, Y., Sun, J., Su, L., & Xu, T. (2023) · Pharmacognosy Magazine · doi:10.1177/09731296231215577 · Cited by 2
Tu, C., Wu, Q., Wang, J., Chen, P., Deng, Y., Li-xiu, Y., Xu, X., Fang, X., & Li, W. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116308 · Cited by 2
Metadata
- Authors
- Saltiel, A. R.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Saltiel, Alan R.
- ORCID
- Saltiel, Alan R.
- Venue
- Journal of Clinical Investigation
- Published
- 2021-01-04
- Volume
- 131
- Issue
- 1
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC7773347
- OpenAlex
- W3119743465
- Cited by
- 446
- References
- 210
- Citations by year
- 2026: 63 · 2025: 113 · 2024: 84 · 2023: 92 · 2022: 72 · 2021: 22
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124496, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- insulin signaling, insulin resistance, metabolic syndrome, insulin receptor, tyrosine kinase, PI3K/Akt signaling, CBL, TC10, glucose homeostasis, vesicle trafficking, insulin degradation, transcription factors, GTPase-activating protein
- MeSH terms
- Animals, Humans, Insulin, Insulin Resistance, Receptor, Insulin, Phosphatidylinositol 3-Kinases, MAP Kinase Signaling System, Metabolic Syndrome, History, 20th Century, History, 21st Century, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.